Transcat, Inc. (NASDAQ:TRNS) Receives $111.50 Average Target Price from Analysts

Transcat, Inc. (NASDAQ:TRNS) has received an average recommendation of “Hold” from the five analysts that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $111.50.

A number of research firms recently weighed in on TRNS. StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Craig Hallum lifted their target price on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Northland Securities reaffirmed a “market perform” rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Finally, HC Wainwright cut their target price on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th.

Transcat Trading Down 1.3 %

NASDAQ TRNS opened at $69.07 on Wednesday. Transcat has a 12 month low of $67.56 and a 12 month high of $147.12. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The company has a market capitalization of $642.97 million, a price-to-earnings ratio of 37.34 and a beta of 0.66. The company’s fifty day moving average price is $82.92 and its two-hundred day moving average price is $102.72.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter in the previous year, the business earned $0.56 EPS. As a group, research analysts predict that Transcat will post 2.3 earnings per share for the current fiscal year.

Insider Buying and Selling at Transcat

In related news, Director Craig D. Cairns purchased 1,200 shares of Transcat stock in a transaction on Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the completion of the transaction, the director now directly owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. This represents a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 2.30% of the company’s stock.

Hedge Funds Weigh In On Transcat

Several large investors have recently made changes to their positions in the business. Neuberger Berman Group LLC lifted its position in shares of Transcat by 1.8% during the 4th quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock worth $92,415,000 after purchasing an additional 15,723 shares during the last quarter. Champlain Investment Partners LLC lifted its position in shares of Transcat by 35.7% during the 4th quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company’s stock worth $58,754,000 after purchasing an additional 146,150 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Transcat by 178.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company’s stock worth $54,837,000 after purchasing an additional 332,064 shares during the last quarter. Geode Capital Management LLC raised its holdings in Transcat by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 219,354 shares of the scientific and technical instruments company’s stock valued at $23,200,000 after acquiring an additional 1,881 shares in the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in Transcat by 5.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 209,200 shares of the scientific and technical instruments company’s stock valued at $22,121,000 after acquiring an additional 10,186 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.